Related Experiment Video
Updated: Jul 5, 2026

Methods for Intravenous Self Administration in a Mouse Model
Published on: December 8, 2012
Desmopressin for nocturnal enuresis in nephrogenic diabetes insipidus
Abstract:
We have investigated two unrelated families, in which two children had inherited primary nocturnal enuresis, and nephrogenic diabetes insipidus caused by new mutations in the aquaporin-2 gene (AQP2). The mutant AQP2 proteins were inactive, suggesting that administration of desmopressin could not concentrate the urine in these patients. However, treatment with desmopressin resolved primary nocturnal enuresis completely. This observation questions the notion that desmopressin resolves primary nocturnal enuresis through pharmacological manipulation of renal concentrating ability only. Desmopressin might also act on extrarenal targets such as the central nervous system.
Related Concept Videos
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Nephrotic Syndrome III : Nursing Management
Peritoneal Dialysis I: Introduction and Procedure
Diabetes Insipidus I: Introduction
Diabetes Insipidus II: Pathophysiology
Diabetic Nephropathy

